100 related articles for article (PubMed ID: 2985264)
21. Long-term effect of pizotifen treatment on growth hormone levels of underweight children, including those with anorexia nervosa.
Dolecek R; Janstová V
Pharmatherapeutica; 1985; 4(2):81-7. PubMed ID: 4059293
[TBL] [Abstract][Full Text] [Related]
22. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine.
Symon DN; Russell G
Arch Dis Child; 1995 Jan; 72(1):48-50. PubMed ID: 7717738
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen.
Behan PO; Connelly K
Headache; 1986 May; 26(5):237-9. PubMed ID: 3522482
[No Abstract] [Full Text] [Related]
24. Onset of action of various migraine prophylactics.
Amery WK
Cephalalgia; 1988; 8 Suppl 8():11-3. PubMed ID: 3180197
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis of migraine in children.
Bille B; Ludvigsson J; Sanner G
Headache; 1977 May; 17(2):61-3. PubMed ID: 324951
[No Abstract] [Full Text] [Related]
26. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis.
Cerbo R; Casacchia M; Formisano R; Feliciani M; Cusimano G; Buzzi MG; Agnoli A
Cephalalgia; 1986 Mar; 6(1):15-8. PubMed ID: 3516406
[TBL] [Abstract][Full Text] [Related]
27. Platelet 3H ketanserin binding in migraine.
Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
[TBL] [Abstract][Full Text] [Related]
28. Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.
MacGilchrist AJ; Deighton NM; Hamilton CA; Reid JL
Br J Clin Pharmacol; 1990 Oct; 30(4):644-7. PubMed ID: 1963313
[TBL] [Abstract][Full Text] [Related]
29. Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis.
Kangasniemi P
Headache; 1979 May; 19(4):219-22. PubMed ID: 156165
[No Abstract] [Full Text] [Related]
30. [Etiology and treatment of migraine].
Petelin LS; Shtok VN; Pigarev VA
Sov Med; 1976 Nov; (11):62-5. PubMed ID: 1006395
[No Abstract] [Full Text] [Related]
31. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
Wörz R; Drillisch C
MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
[No Abstract] [Full Text] [Related]
32. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
33. [Significance of the contribution of pizotifen in correcting appetite disorders and weight insufficiencies].
Blouza Chachoub S; Achour A; Ben Mansour A; Fareh N; Nagati K; Kallal Z
Tunis Med; 1989 Mar; 67(3):207-12. PubMed ID: 2756581
[No Abstract] [Full Text] [Related]
34. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis.
Osterman PO
Acta Neurol Scand; 1977 Jul; 56(1):17-28. PubMed ID: 327746
[TBL] [Abstract][Full Text] [Related]
35. A cooperative study on the clinical aspects of migraine and vascular headache and their response to sandomigran.
Espadaler JM; Gimeno A; Lage AM
Arch Neurobiol (Madr); 1974; 37 SUPPL():206-26. PubMed ID: 4462482
[No Abstract] [Full Text] [Related]
36. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
37. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
Dlohozková N; Metys J; Valchár M; Soucek R
Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
[No Abstract] [Full Text] [Related]
38. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
39. [Sanmigran].
Benoit P; Peutillot A
Soins Psychiatr; 1987 Feb; (76):I-II. PubMed ID: 3646752
[No Abstract] [Full Text] [Related]
40. [Value of Sanmigran in treatment of so called digestive migraine].
Chevrel B
Med Chir Dig; 1976; 5(3):167-70. PubMed ID: 1004048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
